Jushi Holdings (JUSHF) Total Debt (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Total Debt came in at $231.4 million in Q1 2026, up 15.25% year-on-year from $200.7 million in Q1 2025, and up 8.89% on a QoQ basis from $212.5 million in Q4 2025.
Jushi Holdings (JUSHF) Total Debt (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Total Debt data on file, last reported at $231.4 million in Q1 2026.
- On a quarterly basis, Total Debt rose 15.25% year-over-year to $231.4 million in Q1 2026; TTM through Mar 2026 was $231.4 million, a 15.25% increase from a year earlier, with the FY2025 full-year figure at $212.5 million, up 12.44% from the prior year.
- Total Debt for Q1 2026 stood at $231.4 million, up from $212.5 million in the prior quarter.
- Over the last five years, Total Debt for JUSHF reached as high as $286.9 million in Q1 2024 and fell as low as $186.0 million in Q2 2022.
- Historically, Total Debt has averaged $214.3 million across 5 years, with a median of $201.6 million in 2024.
- Across the five-year window, Total Debt jumped 57.14% in 2022 and plunged 30.04% in 2025, its largest moves.
- Year by year, Total Debt stood at $198.0 million in 2022, then rose by 7.37% to $212.6 million in 2023, then declined by 11.1% to $189.0 million in 2024, then increased by 12.44% to $212.5 million in 2025, then rose by 8.89% to $231.4 million in 2026.
- Per Business Quant data, the three most recent Total Debt figures were $231.4 million in Q1 2026, $212.5 million in Q4 2025, and $253.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 231.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 231.35 Mn |
| Dec 31, 2025 | 212.47 Mn |
| Sep 30, 2025 | 253.46 Mn |
| Jun 30, 2025 | 199.91 Mn |
| Mar 31, 2025 | 200.75 Mn |
| Dec 31, 2024 | 188.97 Mn |
| Sep 30, 2024 | 187.27 Mn |
| Jun 30, 2024 | 202.44 Mn |
| Mar 31, 2024 | 286.93 Mn |
| Dec 31, 2023 | 212.56 Mn |
| Sep 30, 2023 | 247.71 Mn |
| Jun 30, 2023 | 228.22 Mn |
| Mar 31, 2023 | 193.34 Mn |
| Dec 31, 2022 | 197.97 Mn |
| Sep 30, 2022 | 199.90 Mn |
| Jun 30, 2022 | 186.00 Mn |
| Dec 31, 2021 | 125.98 Mn |